Drug Research
mRNA Treatment May Swap Rare Illness Intracellular Proteins
Notably, the interim data from a Phase I/II clinical trial goes on to suggest that mRNA-3927, which happens to be an investigational mRNA therapy from Moderna, can very well be a promising treatment when it comes to propionic acidaemia.
A...
News
Groundbreaking LAI Antipsychotic Now Stands Approved In EU
It is indeed worth noting the fact that the first once-every-two-months long-acting injectable- LAI antipsychotic, given a nod by the European Commission- EC is authorized as a maintenance treatment when it comes to adults with schizophrenia in the EU.
The...
Drug Research
The Revolutionizing Universe of Biological Drug Delivery
It is worth noting that the pharmaceutical sector happens to be steadily shifting toward what are known as biologics, or biological drugs. The fact is that the previous generation of chemically synthesized drugs happened to be pretty much one-size-fits-all....
Drug Research
Advanced Drug Delivery Market To Be Driven By Innovation
One of the reports by Towards Healthcare has gone on to forecast that the advanced drug delivery market is going to value $375.86 billion by 2033.
2023 has been termed significant for the progress made when it comes to advanced...
News
How Custom Antibodies Accelerate Drug Discovery and Development
In pharmaceutical research, custom antibodies function as specialized tools designed to assist scientists in better understanding diseases, discovering new treatments, and expediting the process. They operate by targeting specific components of diseases, providing researchers with a clearer understanding of...
IT & Data Management
Automation Use Driven By Pharmaceutical Production Expansion
PMMI, which is the Association for Packaging and Processing Technologies, goes on to note that the forecasted expansion of the pharma machinery market happens to be driven by enhancements in tech, sustainability, automation as well as supply chain issues.
As...
News
Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs
Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group to form a new standalone company. Both Bespak and Recipharm are backed by EQT Private Equity. The spin-out has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read